ADMA Biologics Inc (ADMA)
6.61
-0.06
(-0.90%)
USD |
NASDAQ |
May 02, 10:08
ADMA Biologics Cash from Investing (Quarterly): -1.407M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.407M |
| September 30, 2023 | -0.7566M |
| June 30, 2023 | -0.8726M |
| March 31, 2023 | -1.945M |
| December 31, 2022 | -3.748M |
| September 30, 2022 | -3.380M |
| June 30, 2022 | -3.940M |
| March 31, 2022 | -2.842M |
| December 31, 2021 | -3.676M |
| September 30, 2021 | -2.789M |
| June 30, 2021 | -4.476M |
| March 31, 2021 | -2.571M |
| December 31, 2020 | -3.598M |
| September 30, 2020 | -2.885M |
| June 30, 2020 | -4.168M |
| March 31, 2020 | -2.073M |
| December 31, 2019 | -1.594M |
| September 30, 2019 | -1.972M |
| June 30, 2019 | -0.1352M |
| March 31, 2019 | -0.1105M |
| December 31, 2018 | -0.819M |
| September 30, 2018 | -0.2302M |
| June 30, 2018 | -0.4971M |
| March 31, 2018 | -0.5492M |
| December 31, 2017 | -2.010M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.5699M |
| June 30, 2017 | 12.65M |
| March 31, 2017 | 5.142M |
| December 31, 2016 | 5.626M |
| September 30, 2016 | 0.2389M |
| June 30, 2016 | -8.617M |
| March 31, 2016 | 3.656M |
| December 31, 2015 | 5.401M |
| September 30, 2015 | 4.157M |
| June 30, 2015 | -4.426M |
| March 31, 2015 | -6.874M |
| December 31, 2014 | 1.111M |
| September 30, 2014 | -1.402M |
| June 30, 2014 | -4.369M |
| March 31, 2014 | 0.6202M |
| December 31, 2013 | -2.941M |
| September 30, 2013 | -0.0164M |
| June 30, 2013 | -0.1087M |
| March 31, 2013 | -0.0661M |
| December 31, 2012 | -0.0353M |
| September 30, 2012 | -0.0274M |
| June 30, 2012 | -0.0562M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.476M
Minimum
Jun 2021
-0.1352M
Maximum
Jun 2019
-2.57M
Average
-2.789M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -43.78M |
| ANI Pharmaceuticals Inc | -4.779M |
| Ligand Pharmaceuticals Inc | -10.28M |
| Puma Biotechnology Inc | -8.17M |
| Bristol-Myers Squibb Co | -19.62B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 17.60M |
| Cash from Financing (Quarterly) | -38.99M |
| Free Cash Flow | 3.819M |
| Free Cash Flow Per Share (Quarterly) | 0.0716 |
| Free Cash Flow to Equity (Quarterly) | 27.62M |
| Free Cash Flow Yield | 0.26% |